International Journal of Medical and Pharmaceutical Research
2025, Volume-6, Issue-4 : 690-699 doi: 10.5281/zenodo.16889430
Original Article
Exploring The Impact of Bite-to-Needle Time on Snakebite Complications: Insights from a Study at Tertiary Care Hospital
 ,
 ,
 ,
 ,
 ,
Published
Aug. 16, 2025
Abstract

Background: Snakebite envenoming is an acute life-threatening time-limiting medical emergency necessitating prompt intervention. Timely treatment is often hindered by delayed hospital arrival, delayed treatment, and initial reliance on traditional healers, exacerbating adverse outcomes. This study was conducted to assess whether the bite-to-needle time impacts on complications in snakebite patients, reasons behind the delay in Anti Snake Venom administration, clinico-epidemiological profiles and first aid awareness in victims.

Methods: A hybrid study enrolled 124 snakebite patients admitted between January 2022 and April 2023. Statistical analysis using Chi-square and Pearson's correlation tests evaluated the impact of BNT on complications.

Results: The study revealed higher snakebite incidence in males 53.22%, mostly 74% in 21 to 50 years of age group, farmers 78.22%, from rural areas 77%. A significant positive correlation between BNT and complications is revealed. Notably, 100% of patients with BNT exceeding 8 hours, 96.66% with BNT between 4–8 hours, and 65.58% with BNT within 0–4 hours developed complications. Delayed ASV administration was attributed to various factors, including transportation issues (28.2%), delay after primary health center (PHC) (13.7%), unavailability of personnel for help at incidence place (11.3%), distant hospitals (10.5%), patient ignorance (7.3%), and no sense of damage (6.5%).

Conclusion: This study underscores the critical importance of prompt ASV administration in preventing complications. The direct correlation between BNT and complications highlights the need for enhanced public awareness of snakebite ASV, first aid and timely medical intervention to mitigate morbidity, mortality and to improve the quality of life.

Recommended Articles
Loading Image...
Volume-6, Issue-4
Citations
877 Views
431 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved